Hyster-yale, Inc. (HY) · Nov 19, 2026 · New debt
$135M convertible notes — 7.50% coupon; $18.14 conversion price; $110M term-loan repayment
Hyster-Yale’s convertible-notes pricing extends debt maturities and funds a share repurchase, but adds 7.5% financing costs without fixing weak operations.
Hyster-Yale is trying to finance a recovery in a still-weak lift-truck cycle: Q3 revenue fell 15% year over year to $827.4 million and the company remained loss-making, even as bookings and backlog improved and management began a new cost and capital-efficiency program.
The financing is larger than first announced and extends liquidity. Hyster-Yale priced $135 million of convertible notes, up from the previously announced $125 million, with maturity in November 2031. The proceeds will repay $110 million of the $213.2 million term loan, reducing the immediate refinancing burden and pushing part of the debt farther out.
| Figure | Notes offering | Comparison |
|---|---|---|
| Principal amount (Offering terms) | $135.0M | $125.0M initially announced |
| Coupon (Offering terms) | 7.50% | — |
| Maturity (Offering terms) | Nov. 15, 2031 | — |
| Initial conversion price (Offering terms) | $18.14/share | $15.44 share price |
| Net proceeds (Use of proceeds) | $129.7M | $149.1M if option fully exercised |
| Term-loan repayment (Use of proceeds) | $110.0M | $213.2M outstanding |
| Share repurchase (Concurrent share repurchase) | ~$15.0M | ~971,000 shares |
This is balance-sheet management, not a business breakthrough. The notes carry a substantial 7.50% coupon, implying roughly $10.1 million of annual cash interest on the base issuance, while the transaction leaves the company dependent on additional long-term debt to refinance the remaining term loan. 〔0〕
The equity impact is contained, but not eliminated. The initial conversion price is 17.5% above the November 18 closing price, and capped calls are designed to offset dilution or cash obligations up to a $27.02 cap. The concurrent repurchase also retires roughly 971,000 shares, partly counterbalancing the potential dilution, but it uses capital that otherwise could have supported debt reduction.
The surprise is modest because the financing was already telegraphed. The direction of the transaction was known; the meaningful new information is the $10 million upsizing and the final economics. That makes the event mildly supportive for liquidity, but not enough to change the underlying story of a cyclical manufacturer still trying to convert stronger bookings into profitable growth.
Bottom line: Hyster-Yale has bought more time to navigate the downturn and refinance its term loan, but at a high coupon and with limited proceeds left for operations. It strengthens liquidity modestly without changing the company’s core execution problem.
Offering close scheduled for November 23, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!